Incorporation of a Michael acceptor enhances the antitumor activity of triterpenoic acids.

Basic Information

ID: ALA3612031

Journal: Eur J Med Chem

Title: Incorporation of a Michael acceptor enhances the antitumor activity of triterpenoic acids.

Authors: Heller L, Schwarz S, Perl V, Köwitsch A, Siewert B, Csuk R.

Abstract: Finding and developing drugs for the treatment of cancer has been challenging scientists for many decades, and using compounds of natural origin represents one of several strategies. Triterpenoic acids are a very promising class of secondary metabolites being able to induce apoptosis while their cytotoxicity is low. Therefore, derivatizations have to be conducted to improve cytotoxicity while retaining their ability to induce programmed cell death. The incorporation of a Michael acceptor into molecules resulted very often in drugs of improved cytotoxicity. Thus, in this study we synthesized and evaluated several Michael acceptor substituted compounds derived from glycyrrhetinic, ursolic, oleanolic and platanic acid. The influence of the presence of such a functional group onto the cytotoxicity was investigated in colorimetric sulforhodamine B assays employing several human cancer cell lines. EC50 values in the single-digit micromolar range were measured. Thus, the incorporation of a Michael acceptor unit into triterpenoic acids enhances the cytotoxicity of these compounds significantly.

CiteXplore: 26177446

DOI: 10.1016/j.ejmech.2015.07.004

Patent ID: ┄